New Delhi, March 27 The initial public offering (IPO) of Sai Parenteral, a diversified pharmaceutical formulation company, was fully subscribed on the final day of bidding on Friday, thanks to investments from institutional investors.The IPO received bids for 78,80,972 shares, compared to the...
New Delhi, March 23 Sai Parenteral's Ltd, a diversified pharmaceutical formulation company, raised over Rs 122 crore from anchor investors on Monday, a day before its initial public offering (IPO) opens for subscription.Morgan Stanley Asia (Singapore) Pte Ltd, Kotak Lifesciences Fund, Quant...
anchor investors
capital raising
contract development
equity shares
global formulations
hyderabad
india
initial public offering
injectable products
ipo
manufacturingorganization
new delhi
oral solid dosage formulations
pharmaceutical formulation
sai parenteral
New Delhi, March 9 Mumbai-based True North divested a 3.6 per cent stake in Anthem Biosciences for Rs 1,261 crore through a transaction in the open market on Monday.Private equity firm True North, through its affiliate Viridity Tone LLP, sold a total of 2,03,13,795 shares, representing a 3.62...
anthem biosciences
bengaluru
bulk deal
contract research
development
equity investment
financial transactions
hdfc mutual fund
india
manufacturingorganization
private equity
sbi mutual fund
share acquisition
stock market
true north